The invention refers to new alkylating di- and tripeptides based on a melphalan unit, and one or two additional amino acids or amino acid derivatives, which can be used in the treatment of carcinogenic diseases. Further, the invention refers to a a pharmaceutical composition comprising the alkylating peptides of the invention.
这项发明涉及基于甲
氨膦单元的新烷基化二肽和三肽,以及一到两个额外的
氨基酸或
氨基酸衍
生物,可用于治疗癌症性疾病。此外,该发明涉及一种包含该发明中的烷基化肽的药物组合物。